Huang et al. found that gigantol could inhibit the proliferation and significantly potentiate the anticancer activities of cisplatin (DDP) in breast cancer cells via the PI3K/Akt/mTOR signaling pathway (Huang et al., 2021). Here, AKT1 is linked to breast cancer.